Literature DB >> 25921617

Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors.

Y B Esterson1, M Flusberg2, S Oh2, F Mazzariol2, A M Rozenblit2, V Chernyak2.   

Abstract

AIM: To establish the effect of prolonged hepatobiliary phase (HBP) delay time on hepatic enhancement in patients with parenchymal liver disease (PLD).
MATERIALS AND METHODS: Gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) examinations with HBP were obtained after 20- (HBP-20) and 30-minute (HBP-30) delays in patients with PLD. For each patient, the Model for End-Stage Liver Disease (MELD) score, total and direct bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), prothrombin time (PT), and partial thromboplastin time (PTT) were recorded. Signal intensities of the liver, main portal vein, and spleen on pre-contrast, HBP-20, and HBP-30 were documented. Signal intensities were used to calculate liver relative enhancement (LRE), liver-spleen index (LSI), and liver-portal vein index (LPI) for HBP-20 and HBP-30. Improved hepatic enhancement was considered if two or more indices were higher on HBP-30 than HBP-20. A logistic regression model was constructed with improved hepatic enhancement as the outcome.
RESULTS: One hundred and twenty-nine patients underwent 142 MRIs. Mean LRE, LSI, and LPI each increased from HBP-20 to HBP-30 (p = 0.004, p < 0.001, and p < 0.001, respectively). Seventy-two point five percent of cases demonstrated improved hepatic enhancement. The odds ratios for improved hepatic enhancement were 0.85 for MELD score (p = 0.02) and 3.2 for the 3 T scanner (p = 0.02), adjusted for age and sex.
CONCLUSION: Increasing HBP delay to 30 minutes improves hepatic enhancement in patients with PLD, particularly if using a 3 T scanner. This effect is attenuated with higher MELD scores.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921617     DOI: 10.1016/j.crad.2015.03.005

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms.

Authors:  Jieun Byun; Seongkeun Park; Ji Su Ko; Ji Young Woo
Journal:  Abdom Radiol (NY)       Date:  2021-10-13

2.  Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.

Authors:  Anthony D Nehlsen; Kunal K Sindhu; Thomas Wolken; Fahad Khan; Christopher K Kyriakakos; Stephen C Ward; Erin Moshier; Bachir Taouli; Michael Buckstein
Journal:  Radiol Imaging Cancer       Date:  2022-07

3.  Transient severe motion during arterial phase in patients with Gadoxetic acid administration: Can a five hepatic arterial subphases technique mitigate the artifact?

Authors:  Yu-Dong Xiao; Cong Ma; Jun Liu; Hua-Bing Li; Shun-Ke Zhou; Zi-Shu Zhang
Journal:  Exp Ther Med       Date:  2018-01-17       Impact factor: 2.447

4.  Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT).

Authors:  Massimo Imbriaco; Serena De Luca; Milena Coppola; Mario Fusari; Michele Klain; Marta Puglia; Pierpaolo Mainenti; Raffaele Liuzzi; Simone Maurea
Journal:  Pol J Radiol       Date:  2017-02-01

Review 5.  Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.

Authors:  Vincenza Granata; Roberta Fusco; Antonio Avallone; Orlando Catalano; Francesco Filice; Maddalena Leongito; Raffaele Palaia; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2017-04-28       Impact factor: 2.965

6.  Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin-bilirubin Grade.

Authors:  Yasuo Takatsu; Masafumi Nakamura; Satoshi Kobayashi; Tosiaki Miyati
Journal:  Magn Reson Med Sci       Date:  2020-05-27       Impact factor: 2.471

7.  Evaluation of hypointense liver lesions during hepatobiliary phase MR imaging in normal and cirrhotic livers: is increasing flip angle reliable?

Authors:  Yu-dong Xiao; Cong Ma; Jun Liu; Hua-bing Li; Zi-shu Zhang; Shun-ke Zhou
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

8.  Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.

Authors:  Jian-Wei Wu; Yue-Cheng Yu; Xian-Li Qu; Yan Zhang; Hong Gao
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

9.  Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.

Authors:  Xialing Huang; Liling Long; Jieqin Wei; Yajuan Li; Yuwei Xia; Panli Zuo; Xiangfei Chai
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-29       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.